Other than the widely studied effects of TREM2 function in the context of either Aβ [8, 19] or tau pathologies [20], a recent study found that TREM2 acts at a critical intersection of Aβ and tau pathologies, affecting AD pathogenesis by limiting Aβ plaque-mediated tau pathologies [21]. Here, MAPT is linked to Alzheimer disease.